Paget’s Disease of Bone

Paget’s Disease of Bone (PDB) is a chronic skeletal disorder characterized by disordered bone remodeling. It involves excessive, disorganized bone resorption followed by disorganized bone formation, leading to structurally weak, enlarged, and deformed bones prone to pain, fractures, and secondary malignancy.

PDB results from an interplay between genetic predisposition and environmental triggers. Mutations in the SQSTM1 gene are the most common familial association. Emerging evidence suggests a potential role for paramyxoviral infections in osteoclasts, which may trigger abnormal activation in genetically susceptible individuals.

The disease progresses in three phases: 1) Osteolytic (excessive osteoclast activity), 2) Mixed (osteoclast/osteoblast activity), and 3) Osteosclerotic (predominant, disorganized bone formation). This cycle results in "woven bone" that lacks the structural integrity of lamellar bone, causing enlargement and vascular proliferation.

PDB is most common in individuals of British and Northern European descent. It rarely affects those under 40, with prevalence increasing significantly after age

1. Men are slightly more affected than women.

• Advanced age
• Family history of PDB
• Caucasian ancestry
• SQSTM1 gene mutations
• Previous viral exposures

A. Early Symptoms: Often asymptomatic; incidental findings on imaging.
B. Common Symptoms: Bone pain (dull/aching), localized warmth over the affected bone, joint stiffness.
C. Advanced Symptoms: Bone deformities (bowing of legs), height loss, skull enlargement (increased hat size), hearing loss.
D. Emergency Symptoms: Nerve root compression (cauda equina syndrome), pathologic fracture, intractable pain.

Inspection may show bony enlargement or bowing. Palpation often reveals increased local temperature due to hypervascularity. Auscultation might reveal a bruit over an affected limb due to increased blood flow.

A. Clinical Assessment: Review of skeletal pain and deformity.
B. Laboratory Testing: Serum alkaline phosphatase (ALP) levels.
C. Imaging Studies: Radiography, bone scintigraphy.
D. Functional Tests: Audiometry (if skull involvement).
E. Biopsy Findings: Usually reserved for suspected malignancy; shows mosaic pattern of lamellar bone.
F. Genetic Testing: SQSTM1 screening in familial cases.
G. Differential Diagnosis: Metastatic bone disease, hyperparathyroidism.

Alkaline Phosphatase (ALP)
Type: Blood Test
Purpose: Monitor bone turnover rate
Expected Findings: Elevated
Interpretation: Indicates active disease process

• Radiographs: Gold standard; shows cortical thickening, lytic lesions, and trabecular coarsening.
• Bone Scintigraphy: Highly sensitive for identifying the extent of skeletal involvement ("hot spots").

• Bone Metastases: Differentiated by lack of bone enlargement.
• Osteoporosis: Differentiated by lack of sclerotic lesions.
• Hyperparathyroidism: Differentiated by PTH and calcium levels.

Fractures, secondary osteoarthritis, hearing loss, congestive heart failure (high-output), and osteosarcoma.

A. Lifestyle Modifications: Weight-bearing exercise, fall prevention.
B. Preventive Measures: Adequate calcium and Vitamin D intake.
C. Medical Treatment: Bisphosphonates (inhibits osteoclasts).
D. Surgical Treatment: Osteotomy, joint arthroplasty for severe arthritis.
E. Interventional Procedures: Fixation of impending fractures.
F. Rehabilitation: Physical therapy for mobility.
G. Emergency Management: Decompression surgery for spinal cord involvement.

Generally good with early intervention. Most patients respond well to bisphosphonate therapy; however, the risk of secondary osteosarcoma remains a rare but serious long-term outcome.

No primary prevention exists; secondary prevention involves early diagnosis through ALP monitoring in high-risk family members.

The following homeopathic remedies have been historically indicated for symptoms associated with Paget’s Disease of Bone. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

📊 Bone Health & Osteoporosis Risk Analyzer

Estimates osteoporosis and fracture risk (FRAX-inspired model) based on age, BMI, bone density score (T-score), and lifestyle risk factors. Includes calcium and Vitamin D need estimation.